63 related articles for article (PubMed ID: 8207314)
1. Effect of medication with pravastatin sodium on hemorheological parameters in patients with hyperlipoproteinemia.
Tsuda Y; Satoh K; Takahashi T; Kitadai M; Ichihara S; Ayada Y; Hosomi N; Kawanishi K; Sada Y; Yamamoto M
Int Angiol; 1993 Dec; 12(4):360-4. PubMed ID: 8207314
[TBL] [Abstract][Full Text] [Related]
2. Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
Tsuda Y; Satoh K; Kitadai M; Takahashi T; Izumi Y; Hosomi N
Atherosclerosis; 1996 May; 122(2):225-33. PubMed ID: 8769685
[TBL] [Abstract][Full Text] [Related]
3. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
4. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
[TBL] [Abstract][Full Text] [Related]
5. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects.
Geiss HC; Otto C; Schwandt P; Parhofer KG
Metabolism; 2001 Aug; 50(8):983-8. PubMed ID: 11474489
[TBL] [Abstract][Full Text] [Related]
8. [Lipostat in the treatment of hyperlipoproteinemia].
Růzek V; Procházka J
Vnitr Lek; 1993 Aug; 39(8):769-72. PubMed ID: 8212625
[TBL] [Abstract][Full Text] [Related]
9. The relation between plasma fibrinogen, blood hematocrit and exercise ST segment depressions in hyperlipoproteinemia.
Olsson AG; Blombäck M; Ekelund LG
Artery; 1980; 7(3):215-23. PubMed ID: 7469795
[TBL] [Abstract][Full Text] [Related]
10. The effect of pravastatin and atorvastatin on coenzyme Q10.
Bleske BE; Willis RA; Anthony M; Casselberry N; Datwani M; Uhley VE; Secontine SG; Shea MJ
Am Heart J; 2001 Aug; 142(2):E2. PubMed ID: 11479481
[TBL] [Abstract][Full Text] [Related]
11. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia.
Hedman M; Neuvonen PJ; Neuvonen M; Antikainen M
Clin Pharmacol Ther; 2003 Aug; 74(2):178-85. PubMed ID: 12891228
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors in elderly patients selected by primary care physicians for hypolipemic treatment].
Barretto AC; Wajngarten M; Gebara OC; do Serro Azul JB; Pierri H; Nussbacher A; Pivotto L; Bellotti G; Pileggi F
Arq Bras Cardiol; 1996 Aug; 67(2):93-8. PubMed ID: 9110440
[TBL] [Abstract][Full Text] [Related]
14. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
15. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
Rouleau J
Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
[TBL] [Abstract][Full Text] [Related]
16. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
Toth K; Nemes J; Czopf L; Kapronczay P; Kesmarky G; Juricskay I
Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial.
Zachoval R; Gerbes AL; Schwandt P; Parhofer KG
J Hepatol; 2001 Jul; 35(1):86-91. PubMed ID: 11495047
[TBL] [Abstract][Full Text] [Related]
18. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
20. Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia.
Lee WJ; Lee WL; Tang YJ; Liang KW; Chien YH; Tsou SS; Sheu WH
Clin Chim Acta; 2008 Apr; 390(1-2):49-55. PubMed ID: 18201563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
